CClinicalTrials.gg
CompletedNCT01504893Updated Dec 2, 2022

Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia

An interventional study of Protective one lung ventilation in Acute Respiratory Distress Syndrome, sponsored by Azienda Ospedaliera S. Maria della Misericordia. Completed at 16 sites in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-12-02.

Sponsored by Azienda Ospedaliera S. Maria della Misericordia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
984
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine if a protective ventilatory strategy during one-lung ventilation (OLV) based on low tidal volume, PEEP and alveolar recruitment maneuver can reduce Acute Respiratory Distress Syndrome (ARDS) and Postoperative pulmonary complications (PPCs) after major pulmonary resection.

Primary endpoint: Evaluation of postoperative ARDS incidence

Secondary endpoint: Evaluation od PPC incidence and postoperative outcomes (other complications, unplanned Intensive Care Admission, hospital and ICU length of stay, in-hospital mortality)

Read the detailed description

Pulmonary postoperative complications (PPCs) are the most frequent adverse events after thoracic surgery. Acute respiratory distress syndrome (ARDS) is the most severe among PPCs. Injurious mechanical ventilation is a recognized risk factor associated with ARDS and PPCs after major thoracic surgery.

International literature reports a wide use of tidal volume around 5-6 ml/kg predicted body weight (PBW) during one lung ventilation (OLV) but variable use of PEEP and alveolar recruitment maneuver (ARM).

The aim of this multicenter, randomized, single blind study is to determine if a protective ventilatory strategy during OLV based on low tidal volume, PEEP and alveolar recruitment maneuver compared to conventional strategy can reduce ARDS and PPCs after major pulmonary resection.

Primary outcome is the incidence of in-hospital ARDS.

Secondary outcomes are in-hospital incidence of postoperative pulmonary complications (PPCs), major cardiovascular events, unplanned Intensive Care Unit admission, in-hospital length of stay and mortality

RANDOMIZATION

Patients are randomly assigned to receive protective or conventional OLV according to a computer-generated randomization list (1:1 ratio) before anesthesia induction.

Patients are blinded to the treatment. Anesthesiologists and surgeons are unblinded to the treatment during the surgical procedure and the postoperative outcome assessment.

MEASUREMENTS

Intraoperative collection of ventilatory settings, airway pressures, arterial blood gases analysis at the following time points:

T1: two lung ventilation in supine position before placing the patient in lateral decubitus; T2: 30 minutes after OLV start; T3: 60 minutes after OLV start; T4: 20 minutes after lobectomy/pneumonectomy (during OLV); T5: 15 minutes after ARM in supine position and during two lung ventilation.

Postoperative data collection 1, 12, 24, 36, 48 hours after surgery and at discharge. Arterial blood gas analysis will be performed 1 hour after extubation and 24 and 72 hours after surgery (or in case of respiratory insufficiency).

02

Conditions studied

  • Acute Respiratory Distress Syndrome

Keywords

  • One lung ventilation
  • PEEP
  • thoracic surgery
  • lobectomy and pneumonectomy
  • ARDS
03

In context

Respiratory Distress Syndrome

1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's enrollment of 984 is above the median of 60 across 961 interventional studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Azienda Ospedaliera S. Maria della Misericordia is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients ≥ 18 years
  • ASA IV
  • Elective thoracotomies or thoracoscopic major lung resection surgery (lobectomy, bilobectomy, pneumonectomy)

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery
  • Wedge resection or atypical resection
  • Non-resective lung surgery requiring OLV
  • Patients \< 18 years
  • BMI \< 20 and BMI > 29
  • Heart disease with ejection fraction \<50% and/or severe valvulopathy
  • Pulmonary hypertension
  • Renal failure requiring dialytic treatment
  • Drug addiction
  • Mental retardation, depression and psychiatric disease
  • Motor or sensory deficit
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
984 participants (actual)

Study arms

  • Experimental
    Protective

    Two-lung ventilation (TLV): tidal volume = 8 mL / kg PBW, peak airway pressure ≤ 25 cm H2O, I: E = 1:2; after lung re-expansion to the closure of the chest will set a PEEP of 5 cmH2O OLV (OLV): 4 mL / kg PBW, peak airway pressure ≤ 35 cmH2O, respiratory rate \<30, I:E = 1:2 / 1:3. During OLV in case of desaturation (before increasing the FiO2) and every 60 minutes alveolar recruitment maneuvers followed by the setting of PEEP to 5 cmH2O

    Procedure: Protective one lung ventilation

  • No intervention
    Conventional

    Two-lung ventilation (TLV): tidal volume = 8 mL / kg PBW, peak airway pressure ≤ 25 cmH2O; I: E = 1:2; after lung re-expansion to the closure of the chest PEEP set to 5 cmH2O OLV (OLV): 6 mL / kg PBW, peak airway pressure ≤ 35 cmH2O; I: E = 1:2.

Interventions

  • ProcedureProtective one lung ventilation

    Low tidal volume, PEEP and alveolar recruitment maneuver

06

What researchers measure

Primary outcomes

  1. Acute Respiratory Distress Syndrome (ARDS) incidence

    incidence of ARDS (%)

    Time frame: Hospital stay (7 days average expected)

Secondary outcomes

  1. Postoperative pulmonary complications (PPCs)

    Incidence of PPCs (%)

    Time frame: Hospital stay (7 days average expected)

  2. In-hospital mortality

    To determine mortality (%)

    Time frame: Hospital stay (7 days average aspected)

  3. Postoperative complications

    To determine how many patients (%) would have any postoperative complications

    Time frame: Hospital stay (7 days average expected)

  4. Unplanned Intensive Care Unit (ICU) admission

    To determine how many patients would require an ICU admission (%)

    Time frame: Hospital stay (7 days average aspected)

  5. Intensive Care Unit (ICU) Length of stay

    Length of stay in ICU (days)

    Time frame: Hospital stay (7 days average aspected)

  6. Length of hospital stay

    Duration of hospital length of stay

    Time frame: Hospital stay (7 days average expected)

07

Study locations

16 sites
  • ASST Papa Giovanni XXIII
    Bergamo, Italy
  • IRCCS Policlinico Sant'Orsola-Malpighi
    Bologna, Italy
  • Ospedale Centrale
    Bolzano, Italy
  • Azienda Ospedaliera Brotzu - Ospedale Oncologico Businco
    Cagliari, Italy
  • IRCCS Ospedale Policlinico San Martino
    Genova, Italy
  • Fondazione IRCCS Istituto Nazionale Tumori
    Milan, Italy
  • IRCCS Ospedale San Raffaele
    Milan, Italy
  • Azienda Ospedaliera-Universitaria
    Modena, Italy
  • Istituto Nazionale Tumori Fondazione Pascale
    Napoli, Italy
  • Azienda Ospedaliero-Universitaria
    Padova, Italy
  • IRCCS Centro di Riferimento Oncologico della Basilicata
    Rionero In Vulture, Italy
  • Istituto Nazionale Tumori Regina Elena
    Rome, Italy
  • Azienda Ospedaliera Universitaria Senese
    Siena, Italy
  • Ospedale di Cattinara
    Trieste, Italy
  • Department of Anesthesia and Intensive Care Unit
    Udine, 33100, Italy
  • Ospedale di Circolo e Fondazione Macchi
    Varese, Italy
08

References and documents

Publications

  • Yang M, Ahn HJ, Kim K, Kim JA, Yi CA, Kim MJ, Kim HJ. Does a protective ventilation strategy reduce the risk of pulmonary complications after lung cancer surgery?: a randomized controlled trial. Chest. 2011 Mar;139(3):530-537. doi: 10.1378/chest.09-2293. Epub 2010 Sep 9. PubMed 20829341 ↗
  • Licker M, Diaper J, Villiger Y, Spiliopoulos A, Licker V, Robert J, Tschopp JM. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi: 10.1186/cc7762. Epub 2009 Mar 24. PubMed 19317902 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01504893
Lead sponsor
Azienda Ospedaliera S. Maria della Misericordia
Responsible party
Giorgio Della Rocca (M.D., Azienda Ospedaliera S. Maria della Misericordia) — Principal investigator
First posted
Jan 6, 2012
Start date
Sep 2013
Primary completion
Aug 2016
Completion
Sep 2017
Last update
Dec 2, 2022

Study contacts

Giorgio Della Rocca, MD, Prof
principal investigator · Azienda Ospedaliero-Universitaria S. Maria della Misericordia - Udine. Italy

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion